PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $39,000 | -29.1% | 13,547 | -31.4% | 0.00% | -25.0% |
Q1 2020 | $55,000 | -11.3% | 19,762 | +4.6% | 0.00% | 0.0% |
Q4 2019 | $62,000 | -28.7% | 18,895 | -31.7% | 0.00% | -33.3% |
Q2 2019 | $87,000 | -25.6% | 27,671 | -12.9% | 0.01% | -33.3% |
Q1 2019 | $117,000 | -2.5% | 31,753 | -23.8% | 0.01% | -18.2% |
Q4 2018 | $120,000 | -20.5% | 41,648 | -27.4% | 0.01% | 0.0% |
Q3 2018 | $151,000 | -99.8% | 57,350 | +76.9% | 0.01% | +57.1% |
Q2 2018 | $75,874,000 | +270878.6% | 32,425 | +229.3% | 0.01% | +133.3% |
Q1 2018 | $28,000 | +75.0% | 9,846 | +72.3% | 0.00% | +200.0% |
Q4 2017 | $16,000 | +33.3% | 5,713 | +65.0% | 0.00% | 0.0% |
Q3 2017 | $12,000 | +33.3% | 3,462 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $9,000 | -96.4% | 3,462 | -95.7% | 0.00% | -95.7% |
Q2 2016 | $251,000 | -5.6% | 79,817 | 0.0% | 0.02% | -8.0% |
Q1 2016 | $266,000 | -37.7% | 79,817 | -33.8% | 0.02% | -35.9% |
Q4 2015 | $427,000 | +1155.9% | 120,638 | +1674.6% | 0.04% | +1200.0% |
Q3 2015 | $34,000 | -90.0% | 6,798 | -84.6% | 0.00% | -93.0% |
Q4 2014 | $339,000 | – | 44,045 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |